Fenimore Christopher R. 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Feb 12, 2024
Insider Transaction Report
Form 4
Fenimore Christopher R.
VP, Controller
Transactions
- Sale
Common Stock
2024-02-09$954.57/sh−1,100$1,050,027→ 14,972 total - Sale
Common Stock
2024-02-09$950.49/sh−344$326,969→ 18,947 total - Sale
Common Stock
2024-02-09$951.39/sh−487$463,327→ 18,460 total - Sale
Common Stock
2024-02-09$952.62/sh−1,046$996,441→ 17,414 total - Sale
Common Stock
2024-02-09$953.47/sh−1,342$1,279,557→ 16,072 total - Sale
Common Stock
2024-02-09$955.00/sh−600$573,000→ 14,372 total
Holdings
- 4,269(indirect: 2022 GRAT)
Common Stock
- 1,897(indirect: By Trust)
Common Stock
- 460(indirect: By Trust)
Common Stock
- 1,473(indirect: 2021 GRAT)
Common Stock
- 1,499(indirect: By 401(k))
Common Stock
- 461(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Represents volume-weighted average price of sales of 344 shares of Company stock on February 9, 2024 at prices ranging from $950.33 to $950.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 487 shares of Company stock on February 9, 2024 at prices ranging from $951.03 to $951.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 1,046 shares of Company stock on February 9, 2024 at prices ranging from $952.11 to $952.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 1,342 shares of Company stock on February 9, 2024 at prices ranging from $953.02 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 1,100 shares of Company stock on February 9, 2024 at prices ranging from $954.00 to $954.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
- [F6]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.